Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Dec;15(4):532-535.
doi: 10.26574/maedica.2020.15.4.532.

Atypical Site of Venous Thrombosis Despite Appropriate Anticoagulation in a Patient with Myeloproliferative Neoplasm

Anca Balinisteanu  1 , Diana Mihalcea  1 , Ioan Gemescu  1 , Gabriela Bicescu  1 , Roxana Rimbas  1 , Mircea Cinteza  1 , Dragos Vinereanu  1
Affiliations
Editorial

Atypical Site of Venous Thrombosis Despite Appropriate Anticoagulation in a Patient with Myeloproliferative Neoplasm

Anca Balinisteanu et al. Maedica (Bucur). 2020 Dec.

Abstract

The following case report and literature review will emphasize the individualized therapeutic management of a complex prothrombotic pathology. The onset of acute portal vein thrombosis in a patient with atrial fibrillation and good compliance to anticoagulation with a direct oral anticoagulant, who associates significant thrombocytosis, after excluding predisposing inflammations, infections or solid neoplasia, raises the diagnostic suspicion of myeloproliferative disorder, and imposes a complex interdisciplinary approach.

PubMed Disclaimer

Figures

FIGURE 1.
FIGURE 1.
Abdominal computer tomography identifies (red arrows) thrombosis of portal vein trunk and left portal branch (A, B); patent superior mesenteric vein (C); and hepatic perfusion disorders and splenic infarcts (D)
FIGURE 2.
FIGURE 2.
Six months follow-up abdominal computer tomography reveals (red arrows) recanalization of portal vein trunk (A, B); patent mesenteric vein (C); and persistent hepatic perfusion disorders and splenic infarcts (D)
See this image and copyright information in PMC

References

    1. Reikvam H, Tiu RV. Venous thromboembolism in patients with essential thrombocythemia and polycythemia vera. Leukemia. 2012;26:563–571. - PubMed
    1. Kreher S, Ochsenreither S, Trappe R.U et al. Prophylaxis and management of venous thromboembolism in patients with myeloproliferative neoplasms: consensus statement of the Haemostasis Working Party of the German Society of Hematology and Oncology (DGHO), the Austrian Society of Hematology and Oncology (OGHO) and Society of Thrombosis and Haemostasis Research. Ann Hematol. 2014;93:1953–1963. - PubMed
    1. Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127:2391. - PubMed
    1. Konstantinides SV, Meyer G, Becattini C, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). Eur Heart J. 2020;41:543–603. - PubMed
    1. Agnelli G, Becattini C, Meyer G, et al. Apixaban for the treatment of venous thromboembolism associated with cancer. N Engl J Med. 2020;382:1599–607. - PubMed

Publication types

LinkOut - more resources